Company Overview
ENANTA PHARMACEUTICALS INC
ENTARevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
65M
2025 FY
Net Income
-82M
2025 FY
Shares Outstanding
0M
2025 FY
EPS
-3.84USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1177648
Exchange
Nasdaq
Location
US